2026-07-01 · birth control, hormonal contraception, oral contraceptive, DMPA, Depo-Provera, IUD, weight gain · 15 min read

Does birth control cause weight gain?

For most methods, no. The 2014 Cochrane review by Gallo and colleagues pooled 49 randomized and prospective studies of combined hormonal contraception (the pill, ring, and patch) and found no clinically meaningful difference in weight change versus placebo or non-hormonal comparators. The 2016 Cochrane review by Lopez found the same null result for progestin-only pills, and the 2013 Vickery review in Contraception found hormonal IUDs and the etonogestrel implant to be weight-neutral in most studies. The one clear exception is DMPA (Depo-Provera), which produces an average 2 kg gain at 12 months and about 3.5 kg at 24 months (Lopez 2013 Cochrane). Fluid-related bloating in the first 1 to 3 months of a new combined hormonal method is common but typically resolves by month 6.

Does the Depo shot make you gain weight?

Yes — DMPA (Depo-Provera) is the one contraceptive with a robust, reproducible weight signal. The 2013 Cochrane review by Lopez and the Berenson 2009 prospective cohort in Obstetrics and Gynecology both documented an average gain of about 2 kg at 1 year and 3.5 kg at 2 years. The signal is largest in two subgroups: adolescents and women whose starting BMI is 30 or higher, where individual gains of 5 kg or more in a year are common (Bonny 2006 in Pediatrics). The mechanism appears to be increased appetite and a small drop in resting energy expenditure driven by DMPA's strong estrogen-suppressing effect. If weight is a priority for you and you are choosing a method, DMPA would generally not be the first option — the pill, ring, patch, IUDs, implant, and progestin-only pill all sit at essentially zero weight change.

Which IUD is best for weight loss?

No IUD is a weight-loss device — hormonal IUDs (Mirena, Liletta, Kyleena, Skyla) and the copper IUD (Paragard) are all essentially weight-neutral in the published literature (Vickery 2013 in Contraception; Dahlgren 2014 in Contraception). The one indirect benefit worth naming: the levonorgestrel IUD reduces menstrual blood loss by roughly 90 percent (Lethaby 2015 Cochrane), which can resolve iron-deficiency anemia. Women whose fatigue, exercise intolerance, and hair shedding come from heavy-period-driven iron deficiency sometimes see improved energy and activity after IUD placement, and the downstream effect on weight is real — but it comes from restored capacity, not from the device itself.

Will the pill stop my GLP-1 from working?

For most oral contraceptives, no — the pill and a GLP-1 (semaglutide, liraglutide, tirzepatide) can be taken together without dose changes. Two situations do need attention. First, tirzepatide (Mounjaro, Zepbound) reduces oral contraceptive absorption enough that the FDA labeling recommends an additional barrier method or a switch to a non-oral contraceptive for 4 weeks after starting tirzepatide and after each dose increase. Second, if any GLP-1 causes persistent vomiting in the first weeks, oral contraceptive efficacy can drop the same way it would with any stomach bug — use a barrier method for the rest of that pack. Non-oral hormonal methods (patch, ring, IUD, implant, DMPA) are not affected.

I gained 10 pounds on birth control — should I switch?

Not automatically. If the method is a non-DMPA method (the pill, ring, patch, IUD, implant, or progestin-only pill), the evidence points strongly to something other than the method as the driver. Before switching, track weight, sleep, activity, and food intake for 4 to 6 weeks and ask your clinician to check thyroid function (TSH), fasting glucose or HbA1c, and any new medications you've started. Age-related background gain, a new SSRI, a corticosteroid course, an undiagnosed thyroid problem, or the perimenopausal transition can all masquerade as method-related gain. If you are on DMPA and have gained weight at month 12, switching to a levonorgestrel IUD, implant, or combined oral contraceptive is a reasonable conversation to have with your prescriber (Lopez 2013 Cochrane).

Is there a birth control that helps with PCOS weight gain?

Combined hormonal contraception with an anti-androgenic progestin (drospirenone in Yaz or Yasmin) is first-line for PCOS-related hirsutism, acne, and cycle regularity per the 2015 AACE/ACE PCOS guideline (Goodman 2015) and the 2023 international PCOS evidence-based guideline. The pill does not cause weight gain in PCOS, but it does not cause weight loss either — the weight-loss work in PCOS comes from resolving insulin resistance through diet, exercise, sleep, sometimes metformin, and increasingly GLP-1 medications. What the pill does is treat the androgen-driven skin and cycle symptoms and reduce endometrial cancer risk in a group with chronic anovulation. It is a treatment for PCOS symptoms, not a treatment for PCOS weight.

Can I take birth control while breastfeeding?

Yes — but the method matters. The CDC US Medical Eligibility Criteria and the 2024 ACOG Practice Bulletin 206 both classify progestin-only methods (the mini-pill, levonorgestrel IUD, etonogestrel implant, and DMPA) as safe from the first postpartum day and compatible with breastfeeding. Combined hormonal contraception (the pill, ring, patch) is generally deferred until at least 4 to 6 weeks postpartum because the estrogen can reduce milk supply during early lactation and because postpartum venous-thromboembolism risk is elevated. Postpartum weight is determined by pre-pregnancy weight, gestational gain, breastfeeding, sleep, and behavior — not by the contraceptive method.

Does coming off birth control cause weight loss?

Usually not, with one partial exception. For combined hormonal methods, progestin-only pills, IUDs, and the implant, stopping doesn't consistently produce weight loss because the method wasn't driving weight to begin with — a small amount of first-3-month fluid retention may resolve, but that is grams, not pounds. DMPA is different: the weight gained during use frequently does not reverse after discontinuation (Berenson 2009 Obstetrics and Gynecology; Lopez 2013 Cochrane). If you stopped a method and expected significant weight loss that hasn't come, the honest answer is that the method probably wasn't the cause — and the same workup for background drivers (thyroid, medications, sleep, activity) applies.

Birth Control and Weight: What Causes Gain and What Doesn’t

Quick stats

• Gallo 2014 Cochrane on combined hormonal contraception: 49 studies, no clinically meaningful weight difference vs comparators
• Lopez 2016 Cochrane on progestin-only pills: null result — no consistent weight signal
• Lopez 2013 Cochrane on DMPA (Depo-Provera): +2 kg at 12 months, +3.5 kg at 24 months
• Levonorgestrel IUD, copper IUD, and Nexplanon implant: weight-neutral in most studies (Vickery 2013 Contraception)
• US women currently using a contraceptive method: ~65% of reproductive-age women

The honest picture, in one paragraph

Most birth control does not change body weight. Gallo 2014 (Cochrane Database of Systematic Reviews) pooled 49 randomized and prospective studies of combined hormonal contraception — the pill, ring, and patch — and found no clinically meaningful difference in weight change compared with placebo or non-hormonal comparators. Lopez 2016 (Cochrane) reached the same null result for progestin-only pills, and Vickery 2013 (Contraception) found the levonorgestrel IUD, copper IUD, and etonogestrel implant to be weight-neutral in most studies. The one method with a robust weight signal is DMPA (Depo-Provera) — Lopez 2013 (Cochrane) and the Berenson 2009 (Obstetrics and Gynecology) prospective cohort both documented an average ~2 kg gain at 12 months and ~3.5 kg at 24 months, with the effect concentrated in adolescents and women with baseline BMI ≥30 (Bonny 2006 Pediatrics). ACOG 2024 Practice Bulletin 206 and the 2024 FSRH UK clinical guidance both frame this the same way: name the DMPA-specific signal in counseling, but do not steer women away from any non-DMPA method on weight concerns alone.

The reason this article exists is that the fear of birth-control weight gain drives real decisions — women switching off methods that were working for them, avoiding contraception entirely, and blaming the pill for gain that had nothing to do with it. The rest of the piece walks through the four functional categories, the actual weight numbers per method, why DMPA is the outlier, a 5-step protocol for anyone gaining weight on a method, and the intersections with PCOS, perimenopause, postpartum, and GLP-1 medications.

How birth control methods are categorized for weight discussion

Contraceptives split into four functional categories that predict most of the weight conversation.

Reproductive-health conditions that co-occur with the contraceptive choice — PCOS, endometriosis, perimenopause, and the body-composition shift covered in weight loss for women over 40 — often drive weight changes that get blamed on the method. Separating the two is most of the clinical work.

Why DMPA is the outlier — and why the pill isn’t

Four mechanisms explain almost all of the honest weight picture.

1. DMPA suppresses estrogen and drives appetite and a small drop in resting energy expenditure

Berenson 2009 (Obstetrics and Gynecology) tracked more than 700 DMPA users prospectively and documented a dose-dependent appetite increase and a small reduction in resting energy expenditure. Bonny 2006 (Pediatrics) confirmed the same pattern in adolescents, where the signal is largest. The mechanism appears to be DMPA’s strong estrogen-suppressing effect at the hypothalamus, which shifts appetite regulation upward. Women with a baseline BMI ≥30 also gain more on DMPA than lower-BMI women, so the appetite drive stacks with an environment that already favors gain. When appetite is the visible symptom, the routines covered in appetite suppressant supplements and the low TDEE guide are relevant.

2. Combined hormonal contraceptives, IUDs, and implants do not produce appetite or energy-expenditure changes large enough to drive sustained gain

The Gallo 2014 Cochrane pooled analysis and the Vickery 2013 review both make this point cleanly: whatever biological effects estrogen and lower-dose progestins have, they do not reproducibly translate to measurable weight change over 12 months across randomized and prospective evidence. Reported gain on these methods is typically attributable to age-related background gain (roughly 0.4 to 0.6 kg per year in women in their 20s and 30s), lifestyle change, or short-term fluid retention that resolves. When a woman gains weight on a non-DMPA method, the drivers covered in weight loss plateau and why am I not losing weight are more useful frames than the pill.

3. Fluid retention in months 1–3 is common but resolves

Both the Gallo 2014 review and Berenson’s prospective work note that up to 30 percent of women on a new combined hormonal method report mild fluid-related weight change — typically 1 to 2 kg — in the first 1 to 3 months. This is estrogen-mediated sodium and water retention, and it typically resolves by month 6 without any intervention. The clinical lesson is not to make a method-change decision in month 2. See weight loss plateau for how to read short-term scale movement.

4. Co-existing reproductive-health conditions drive weight changes that get blamed on contraception

Goodman 2015 (AACE/ACE PCOS guideline) and Bedaiwy 2017 (Obstetrics and Gynecology endometriosis review) both document how the conditions themselves — not the contraceptive prescribed to treat them — drive weight change. PCOS is the archetype: insulin resistance and androgen excess produce gain independent of any pill, and the pill is often the intervention. Perimenopausal weight gain is age- and hormone-transition-driven, not method-driven. Cross-links: PCOS and weight loss, endometriosis and weight loss, menopause and weight loss, weight loss for women over 40.

How much each method actually shifts weight

This is the honest 2026 lookup — use it for a prescriber conversation, not for a self-directed switch.

5-step birth-control-and-weight protocol

Step 1: If you are choosing a method and weight is a concern, DMPA is not the first choice

ACOG 2024 Practice Bulletin 206, Lopez 2013 Cochrane, and the 2024 FSRH UK clinical guidance all agree on the same simple framing: name the DMPA signal explicitly in the counseling conversation, and if weight is a priority, choose a combined hormonal method, levonorgestrel IUD, copper IUD, etonogestrel implant, or progestin-only pill first. DMPA remains the right method for some patients (severe anemia unresponsive to other options, specific medical contraindications to estrogen, or patient preference for injection frequency), but weight-concerned patients should hear the numbers before choosing it. For men in the same household who are also thinking about weight, see weight loss for men; the weight loss for women over 40 guide covers method choice in the perimenopausal transition.

Step 2: If you have gained weight on a non-DMPA method, separate method effect from background drivers before switching

Gallo 2014 is unequivocal: the method is unlikely to be the driver. Before requesting a switch, spend 4 to 6 weeks tracking weight, sleep, activity, and food intake, and ask your clinician to check TSH (thyroid), fasting glucose or HbA1c, and any newly prescribed medications. Antidepressants (see antidepressants and weight changes), corticosteroid courses, gabapentinoids, and antipsychotics are the common culprits. Thyroid disease — particularly Hashimoto’s — is the other high-yield cause. Cross-links: thyroid and weight loss, Hashimoto’s thyroiditis and weight loss, why am I not losing weight, weight loss plateau.

Step 3: If you are on DMPA and have gained weight at month 12, switch is a reasonable conversation

Lopez 2013 Cochrane and Berenson 2009 both show that the DMPA-attributed gain often persists after discontinuation and does not reliably reverse with method change alone — so if a method change is going to happen, sooner is better than later. Reasonable next choices include the levonorgestrel IUD, the etonogestrel implant, a combined oral contraceptive if not contraindicated, or the progestin-only pill. The change requires a taper conversation with the prescriber; the last dose keeps working for roughly 12 weeks, so the switch is a transition, not a stop-and-start. Weight regained on DMPA is best addressed with the standard behavior levers covered in weight loss plateau.

Step 4: If you are starting a GLP-1 medication while on hormonal contraception, coordinate the two

For daily oral contraceptives, injectable contraceptives, IUDs, and implants, no dose adjustment of the contraceptive is needed alongside a GLP-1 (Wilding 2021 NEJM STEP-1). Two situations do need attention. First, tirzepatide (Mounjaro, Zepbound) reduces oral contraceptive absorption enough that FDA labeling recommends an additional barrier method or switching to a non-oral method for 4 weeks after starting tirzepatide and after each dose increase. Second, persistent vomiting in the early weeks of any GLP-1 can reduce oral contraceptive efficacy the same way any stomach illness would — use a barrier for the rest of that pill pack. See GLP-1 weight loss overview, GLP-1 medications compared, Ozempic side effects, Mounjaro weight loss, and Zepbound weight loss.

Step 5: If you are perimenopausal or postpartum, expect background weight changes that have nothing to do with the method

Bedaiwy 2017 and ACOG’s perimenopause and postpartum guidance both make the point directly: the perimenopausal transition and the first year postpartum are periods of predictable body-composition change driven by hormones, sleep disruption, and life-stage shifts — not by contraception. Attributing this to the pill is a common but preventable clinical detour. Cross-links: menopause and weight loss, weight loss for women over 40, weight loss after pregnancy.

What contraceptive choices actually do — comparison

Special situations

PCOS, hirsutism, and contraception

The Goodman 2015 AACE/ACE PCOS guideline and the 2023 international PCOS evidence-based guideline both name combined hormonal contraception with an anti-androgenic progestin (drospirenone) as first-line pharmacologic treatment for PCOS-related hirsutism, acne, and menstrual irregularity. The pill treats the symptoms; PCOS itself — driven by insulin resistance and androgen excess — is what drives PCOS-related weight gain, not the pill. Weight-loss work in PCOS runs through the standard levers: modest calorie deficit, higher protein, resistance training, sleep, sometimes metformin, and increasingly GLP-1 medications. Two important cautions: any woman with PCOS on a GLP-1 who is not trying to conceive should still use effective contraception (unintended pregnancies on GLP-1s are rising), and drospirenone contraceptives share a small VTE-risk elevation with other combined hormonal methods. Cross-links: PCOS and weight loss, insulin resistance and weight loss.

Postpartum and breastfeeding

ACOG 2024 Practice Bulletin 206 and the CDC US Medical Eligibility Criteria both classify progestin-only methods — the mini-pill, levonorgestrel IUD, etonogestrel implant, and DMPA — as safe from the first postpartum day and compatible with breastfeeding. Combined hormonal methods are generally deferred until at least 4 to 6 weeks postpartum because postpartum VTE risk is elevated and because estrogen can reduce milk supply during early lactation. Postpartum weight trajectory is determined by pre-pregnancy weight, gestational weight gain, breastfeeding, sleep, and behavior — not by the contraceptive method itself. Women with a history of gestational diabetes should also consider that DMPA can worsen insulin sensitivity, which makes it a less favorable choice in that specific group. Cross-links: weight loss after pregnancy, gestational diabetes and weight loss.

Heavy menstrual bleeding, endometriosis, and the IUD indirect-benefit story

Lethaby 2015 (Cochrane) documented the levonorgestrel IUD’s roughly 90 percent reduction in menstrual blood loss — enough that the device is a first-line treatment for heavy menstrual bleeding and a common adjunct in endometriosis and fibroid management. The IUD itself is weight-neutral, but the downstream effects of resolving iron-deficiency anemia are real: restored exercise capacity, better sleep, reversed hair shedding, and a return of the everyday energy that supports weight-related behavior. Attribution matters here — the IUD is not causing weight loss; it is resolving the anemia that was quietly costing capacity. Cross-links: iron deficiency anemia and weight loss, endometriosis and weight loss, hair loss during weight loss.

Red flags — when to see a doctor

• Unintentional ≥5% weight gain in 6 months on a non-DMPA method despite stable diet, activity, and no new medications — workup for thyroid disease, Cushing’s, PCOS, insulin resistance, or polypharmacy first; the method is unlikely to be the cause.
• Severe headache, visual changes, or one-sided weakness on a combined hormonal method — same-week call to rule out migraine with aura and elevated stroke risk; switch to a progestin-only or non-hormonal method (ACOG 2024).
• Calf swelling, chest pain, or shortness of breath on a combined hormonal method — emergency-department evaluation to rule out DVT and pulmonary embolism.
• Persistent depression or mood change after starting a hormonal method — Pratt 2015 (Cochrane) covers the combined-pill mood signal; discuss method change with the prescriber rather than stopping abruptly.
• Persistent vomiting on a GLP-1 medication while taking oral contraception — oral contraceptive efficacy can drop; use a barrier method or switch to a non-oral method per FDA labeling for tirzepatide.
• Pregnancy on an IUD or implant — urgent OB evaluation to rule out ectopic pregnancy.

Birth Control and Weight FAQ

Does birth control cause weight gain? For most methods, no — the pill, ring, patch, IUDs, implant, and progestin-only pill are weight-neutral in pooled evidence. DMPA is the outlier.

Does the Depo shot make you gain weight? Yes — average ~2 kg at 12 months, ~3.5 kg at 24 months, largest in adolescents and higher-BMI users.

Which IUD is best for weight loss? None — hormonal and copper IUDs are weight-neutral. The indirect benefit is resolving heavy-period-driven anemia.

Will the pill stop my GLP-1 from working? Not usually, but tirzepatide reduces oral contraceptive absorption for 4 weeks after starting and each dose increase — use a barrier method during those windows.

I gained 10 pounds on birth control — should I switch? Not automatically. Check thyroid, new medications, sleep, and activity first if you are on a non-DMPA method.

Is there a birth control that helps with PCOS weight gain? No method treats PCOS weight specifically. Drospirenone-containing combined pills are first-line for PCOS symptoms (acne, hirsutism, cycles), not for weight.

Can I take birth control while breastfeeding? Progestin-only methods (POP, LNG-IUD, implant, DMPA) are safe from day one. Defer combined methods until 4 to 6 weeks postpartum.

Does coming off birth control cause weight loss? Rarely. Non-DMPA methods weren’t driving weight; DMPA-attributed gain frequently doesn’t reverse after discontinuation.